Stride Inc Aktie News

Stride, Inc. is rated a buy, with a projected 90% upside to $132.60 per share. LRN has delivered strong enrollment (+11%) and revenue growth (+13%) despite AI disruption concerns. Operating income is outpacing revenue growth, reflecting efficiency gains and prudent management.

We believe Stride (NYSE: LRN) stock merits attention: It is expanding, generating cash, and presently offered at a considerable valuation discount. Firms like this can utilize cash to drive further revenue enhancement or simply reward their shareholders through dividends or stock repurchases.

RESTON, VA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2026 financial results during a conference call scheduled for Tuesday, January 27, 2026 at 5:00 p.m. eastern time (ET).

RESTON, VA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2026 financial results during a conference call scheduled for Tuesday, January 27, 2026 at 5:00 p.m. eastern time (ET).

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU AR...

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Stride (LRN) To Contact Him Directly To Discuss Their Options If you purchased or acquired Stride securities between October 22, 2024 and October 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) ...

Stride, Inc. remains a Buy, with stabilization near support and a strong mean reversion expected post-Q2 results. LRN's platform glitch caused enrollment losses, but double-digit student growth and robust operating leverage signal resilience and future EPS expansion. Street models sub-8% FY2027 EPS growth, but management is limiting intake to restore quality; I expect FY2027 comp benefit and up...

LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”).